Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$133.25
+0.5%
$130.09
$99.71
$141.23
$231.83B0.746.11 million shs6.29 million shs
Carnival Co. & plc stock logo
CCL
Carnival Co. &
$19.54
-0.1%
$19.38
$13.78
$28.72
$22.80B2.526.02 million shs15.35 million shs
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
$17.27
-0.6%
$18.24
$14.21
$29.29
$7.66B2.0912.68 million shs10.62 million shs
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
$225.61
-1.4%
$208.96
$130.08
$277.08
$61.27B2.122.29 million shs1.45 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
+0.55%+2.07%+7.06%+0.90%+26.15%
Carnival Co. & plc stock logo
CCL
Carnival Co. &
-0.13%+4.46%+18.51%-28.19%+33.86%
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
-0.61%-0.67%+10.24%-38.62%+6.63%
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
-1.40%+4.21%+27.03%-15.49%+57.49%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.8907 of 5 stars
2.44.04.24.53.42.52.5
Carnival Co. & plc stock logo
CCL
Carnival Co. &
4.8959 of 5 stars
4.42.00.03.12.41.74.4
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
4.79 of 5 stars
4.42.00.01.22.41.74.4
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
4.9828 of 5 stars
3.55.02.53.43.32.53.8
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.84
Moderate Buy$142.597.01% Upside
Carnival Co. & plc stock logo
CCL
Carnival Co. &
2.71
Moderate Buy$26.5335.73% Upside
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
2.76
Moderate Buy$26.2652.04% Upside
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
2.90
Moderate Buy$273.0521.03% Upside

Current Analyst Ratings Breakdown

Latest CCL, RCL, NCLH, and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/6/2025
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$21.00 ➝ $20.00
5/6/2025
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$220.00 ➝ $230.00
5/1/2025
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$25.00 ➝ $24.00
5/1/2025
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$30.00 ➝ $26.00
5/1/2025
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$27.00 ➝ $18.00
4/30/2025
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$249.00 ➝ $263.00
4/30/2025
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetPositive ➝ Positive$295.00 ➝ $275.00
4/25/2025
Carnival Co. & plc stock logo
CCL
Carnival Co. &
Northcoast Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral
4/25/2025
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
Northcoast Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$21.00
4/25/2025
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
Northcoast Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$279.00
4/23/2025
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$31.00 ➝ $20.00
(Data available from 5/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$42.34B5.48$5.74 per share23.22$22.36 per share5.96
Carnival Co. & plc stock logo
CCL
Carnival Co. &
$25.42B0.90$3.16 per share6.18$8.02 per share2.44
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
$9.42B0.81$1.68 per share10.28$0.71 per share24.33
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
$16.76B3.66$16.98 per share13.29$28.74 per share7.85
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$13.40B$7.7117.4223.252.5231.95%20.74%11.19%7/17/2025 (Estimated)
Carnival Co. & plc stock logo
CCL
Carnival Co. &
$1.92B$1.5014.069.350.737.66%24.13%3.82%6/24/2025 (Estimated)
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
$166.18M$1.7315.859.440.245.87%99.31%3.12%N/A
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
$2.88B$12.0421.1012.850.9017.46%48.97%8.86%7/24/2025 (Estimated)

Latest CCL, RCL, NCLH, and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2025Q1 2025
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
$0.09$0.07-$0.02-$0.09$2.15 billion$2.13 billion
4/29/2025Q1 2025
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
$2.53$2.71+$0.18$2.70$4.02 billion$4.00 billion
4/16/2025Q1 2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.07$1.09+$0.02$0.76$10.38 billion$10.36 billion
3/21/2025Q1 2025
Carnival Co. & plc stock logo
CCL
Carnival Co. &
$0.02$0.13+$0.11-$0.06$5.74 billion$5.81 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.361.77%+7.17%30.61%54 Years
Carnival Co. & plc stock logo
CCL
Carnival Co. &
$2.0010.23%N/A133.33%N/A
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
N/AN/AN/AN/AN/A
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
$3.001.33%N/A24.92%N/A

Latest CCL, RCL, NCLH, and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/6/2025
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
quarterly$0.751.33%6/4/20257/3/2025
2/21/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.591.75%4/15/20254/15/20255/15/2025
2/12/2025
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
quarterly$0.751.17%3/7/20253/7/20254/4/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.32
1.60
1.14
Carnival Co. & plc stock logo
CCL
Carnival Co. &
2.80
0.29
0.25
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
10.35
0.20
0.17
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
2.39
0.17
0.15

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Carnival Co. & plc stock logo
CCL
Carnival Co. &
67.19%
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
69.58%
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
87.53%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Carnival Co. & plc stock logo
CCL
Carnival Co. &
7.60%
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
0.52%
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
7.95%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.74 billion1.73 billionOptionable
Carnival Co. & plc stock logo
CCL
Carnival Co. &
40,0001.17 billion1.04 billionOptionable
Norwegian Cruise Line Holdings Ltd. stock logo
NCLH
Norwegian Cruise Line
38,900443.44 million437.42 millionOptionable
Royal Caribbean Cruises Ltd. stock logo
RCL
Royal Caribbean Cruises
102,500271.56 million247.73 millionOptionable

Recent News About These Companies

ROYAL CARIBBEAN GROUP DECLARES DIVIDEND
ROYAL CARIBBEAN GROUP DECLARES DIVIDEND
A Tale of Two Cruise Line Stocks
William Blair Has Bearish Forecast for RCL Q3 Earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$133.25 +0.65 (+0.49%)
Closing price 05/6/2025 03:59 PM Eastern
Extended Trading
$134.04 +0.79 (+0.59%)
As of 06:20 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Carnival Co. & stock logo

Carnival Co. & NYSE:CCL

$19.54 -0.02 (-0.08%)
Closing price 05/6/2025 03:59 PM Eastern
Extended Trading
$19.70 +0.15 (+0.77%)
As of 06:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America and Australia (NAA) Cruise, Europe and Asia (EA) Cruise Operations, Cruise Support, and Tour and Others. The North America and Australia (NAA) Cruise segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe and Asia (EA) Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Norwegian Cruise Line stock logo

Norwegian Cruise Line NYSE:NCLH

$17.27 -0.10 (-0.55%)
Closing price 05/6/2025 03:59 PM Eastern
Extended Trading
$17.42 +0.15 (+0.87%)
As of 06:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Norwegian Cruise Line Holdings Ltd., together with its subsidiaries, operates as a cruise company in North America, Europe, the Asia-Pacific, and internationally. The company operates through the Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises brands. It offers itineraries ranging from three days to a 180-days calling on various ports, including Scandinavia, Northern Europe, the Mediterranean, the Greek Isles, Alaska, Canada and New England, Hawaii, Asia, Tahiti and the South Pacific, Australia and New Zealand, Africa, India, South America, the Panama Canal, and the Caribbean. It distributes its products through retail/travel advisor and onboard cruise sales channels, as well as meetings, incentives, and charters. Norwegian Cruise Line Holdings Ltd. was founded in 1966 and is based in Miami, Florida.

Royal Caribbean Cruises stock logo

Royal Caribbean Cruises NYSE:RCL

$225.61 -3.14 (-1.37%)
Closing price 05/6/2025 03:59 PM Eastern
Extended Trading
$227.50 +1.89 (+0.84%)
As of 05:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Royal Caribbean Cruises Ltd. operates as a cruise company worldwide. The company operates cruises under the Royal Caribbean International, Celebrity Cruises, and Silversea Cruises brands, which comprise a range of itineraries. As of February 21, 2024, it operated 65 ships. Royal Caribbean Cruises Ltd. was founded in 1968 and is headquartered in Miami, Florida.